The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
Yet today, independent pharmacies like ours face a dire and immediate threat from pharmacy benefit managers (PBMs), whose unchecked practices are jeopardizing patient care and driving community ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...
The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to ...
The agency alleges that PBMs, as they are known, benefit financially when the list price of insulin is higher, enabling them to extract heftier rebates from the manufacturers of a product that is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback